Skip to main content
Top
Published in: Abdominal Radiology 4/2018

01-04-2018 | Pictorial essay

Applications of contrast-enhanced ultrasound in the kidney

Authors: Brittany Kazmierski, Corinne Deurdulian, Hisham Tchelepi, Edward G. Grant

Published in: Abdominal Radiology | Issue 4/2018

Login to get access

Abstract

Incidental discovery of renal lesions on cross-sectional imaging studies performed for other indications is not uncommon. With the increased reliance on medical imaging, the number of incidentally detected renal lesions has also grown over time. While simple cysts account for the majority of these lesions, the presence of complex features within a cystic lesion, such as septations and solid components, can present a confusing picture. Solid lesions, too, can be indeterminate, and distinguishing between benign solid masses (like lipid-poor angiomyolipomas and oncocytomas) and renal cell carcinoma affects patient management and can prevent unnecessary interventions. Indeterminate renal lesions are traditionally further characterized by multiphase imaging, such as contrast-enhanced computed tomography and magnetic resonance imaging. Contrast-enhanced ultrasound (CEUS) is a new, relatively inexpensive technique that has become increasingly employed in the diagnostic workup of indeterminate renal lesions. With its lack of nephrotoxicity, the absence of ionizing radiation, and the ability to evaluate the enhancement pattern of renal lesions quickly and in real-time, CEUS has unique advantages over traditional imaging modalities. This article provides an overview of the current clinical applications of CEUS in characterizing renal lesions, both cystic and solid. Additional applications of CEUS in the kidney, including its roles in renal transplant evaluation and guidance for percutaneous biopsy, will also be briefly discussed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98(18):1331–1334CrossRefPubMed Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98(18):1331–1334CrossRefPubMed
2.
go back to reference Jinzaki M, Tanimoto A, Mukai M, et al. (2000) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 24(6):835–842CrossRefPubMed Jinzaki M, Tanimoto A, Mukai M, et al. (2000) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 24(6):835–842CrossRefPubMed
3.
go back to reference Li X, Liang P, Guo M, et al. (2013) Real-time contrast-enhanced ultrasound in diagnosis of solid renal lesions. Discov Med 16(86):15–25PubMed Li X, Liang P, Guo M, et al. (2013) Real-time contrast-enhanced ultrasound in diagnosis of solid renal lesions. Discov Med 16(86):15–25PubMed
4.
go back to reference Xu ZF, Xu HX, Xie XY, et al. (2010) Renal cell carcinoma: real-time contrast-enhanced ultrasound findings. Abdom Imaging 35(6):750–756CrossRefPubMed Xu ZF, Xu HX, Xie XY, et al. (2010) Renal cell carcinoma: real-time contrast-enhanced ultrasound findings. Abdom Imaging 35(6):750–756CrossRefPubMed
5.
go back to reference Barr RG, Peterson C, Hindi A (2014) Evaluation of indeterminate renal masses with contrast-enhanced US: a diagnostic performance study. Radiology 271(1):133–142CrossRefPubMed Barr RG, Peterson C, Hindi A (2014) Evaluation of indeterminate renal masses with contrast-enhanced US: a diagnostic performance study. Radiology 271(1):133–142CrossRefPubMed
6.
go back to reference King KG, Gulati M, Malhi H, et al. (2015) Quantitative assessment of solid renal masses by contrast-enhanced ultrasound with time–intensity curves: how we do it. Abdom Imaging 40(7):2461–2471CrossRefPubMed King KG, Gulati M, Malhi H, et al. (2015) Quantitative assessment of solid renal masses by contrast-enhanced ultrasound with time–intensity curves: how we do it. Abdom Imaging 40(7):2461–2471CrossRefPubMed
7.
go back to reference McGuire BB, Fitzpatrick JM (2010) The diagnosis and management of complex renal cysts. Curr Opin Urol 20(5):349–354CrossRefPubMed McGuire BB, Fitzpatrick JM (2010) The diagnosis and management of complex renal cysts. Curr Opin Urol 20(5):349–354CrossRefPubMed
8.
9.
go back to reference Hartman DS, Choyke PL, Hartman MS (2004) From the RSNA refresher courses: a practical approach to the cystic renal mass. Radiographics 24(Suppl 1):S101–S115CrossRefPubMed Hartman DS, Choyke PL, Hartman MS (2004) From the RSNA refresher courses: a practical approach to the cystic renal mass. Radiographics 24(Suppl 1):S101–S115CrossRefPubMed
10.
go back to reference Israel GM, Hindman N, Bosniak MA (2004) Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231(2):365–371CrossRefPubMed Israel GM, Hindman N, Bosniak MA (2004) Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231(2):365–371CrossRefPubMed
11.
go back to reference Park BK, Kim B, Kim SH, et al. (2007) Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. Eur J Radiol 61(2):310–314CrossRefPubMed Park BK, Kim B, Kim SH, et al. (2007) Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. Eur J Radiol 61(2):310–314CrossRefPubMed
12.
go back to reference Quaia E, Bertolotto M, Cioffi V, et al. (2008) Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses. Am J Roentgenol 191(4):1239–1249CrossRef Quaia E, Bertolotto M, Cioffi V, et al. (2008) Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses. Am J Roentgenol 191(4):1239–1249CrossRef
13.
go back to reference Ascenti G, Mazziotti S, Zimbaro G, et al. (2007) Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 243(1):158–165CrossRefPubMed Ascenti G, Mazziotti S, Zimbaro G, et al. (2007) Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 243(1):158–165CrossRefPubMed
14.
go back to reference Harvey C, Alsafi A, Kuzmich S, et al. (2015) Role of US contrast agents in the assessment of indeterminate solid and cystic lesions in native and transplant kidneys. Radiographics 35(5):1419–1430CrossRefPubMed Harvey C, Alsafi A, Kuzmich S, et al. (2015) Role of US contrast agents in the assessment of indeterminate solid and cystic lesions in native and transplant kidneys. Radiographics 35(5):1419–1430CrossRefPubMed
15.
go back to reference Forman HP, Middleton WD, Melson GL, McClennan BL (1993) Hyperechoic renal cell carcinomas: increase in detection at US. Radiology 188(2):431–434CrossRefPubMed Forman HP, Middleton WD, Melson GL, McClennan BL (1993) Hyperechoic renal cell carcinomas: increase in detection at US. Radiology 188(2):431–434CrossRefPubMed
16.
go back to reference Jinzaki M, Tanimoto A, Narimatsu Y, et al. (1997) Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 205(2):497–502CrossRefPubMed Jinzaki M, Tanimoto A, Narimatsu Y, et al. (1997) Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 205(2):497–502CrossRefPubMed
17.
go back to reference Xu ZF, Xu HX, Xie XY, et al. (2010) Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med 29(5):709–717CrossRefPubMed Xu ZF, Xu HX, Xie XY, et al. (2010) Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med 29(5):709–717CrossRefPubMed
18.
go back to reference Dechet CB, Bostwick DG, Blute ML, et al. (1999) Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. J Urol 162(1):40–42CrossRefPubMed Dechet CB, Bostwick DG, Blute ML, et al. (1999) Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. J Urol 162(1):40–42CrossRefPubMed
19.
go back to reference Goiney RC, Goldenberg L, Cooperberg PL, et al. (1984) Renal oncocytoma: sonographic analysis of 14 cases. Am J Roentgenol 143(5):1001–1004CrossRef Goiney RC, Goldenberg L, Cooperberg PL, et al. (1984) Renal oncocytoma: sonographic analysis of 14 cases. Am J Roentgenol 143(5):1001–1004CrossRef
20.
go back to reference Quinn MJ, Hartman DS, Friedman AC, et al. (1984) Renal oncocytoma: new observations. Radiology 153(1):49–53CrossRefPubMed Quinn MJ, Hartman DS, Friedman AC, et al. (1984) Renal oncocytoma: new observations. Radiology 153(1):49–53CrossRefPubMed
21.
go back to reference Davidson AJ, Hayes WS, Hartman DS, McCarthy WF, Davis CJ Jr (1993) Renal oncocytoma and carcinoma: failure of differentiation with CT. Radiology 186(3):693–696CrossRefPubMed Davidson AJ, Hayes WS, Hartman DS, McCarthy WF, Davis CJ Jr (1993) Renal oncocytoma and carcinoma: failure of differentiation with CT. Radiology 186(3):693–696CrossRefPubMed
22.
go back to reference Choudhary S, Rajesh A, Mayer NJ, Mulcahy KA, Haroon A (2009) Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 64(5):517–522CrossRefPubMed Choudhary S, Rajesh A, Mayer NJ, Mulcahy KA, Haroon A (2009) Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 64(5):517–522CrossRefPubMed
23.
go back to reference Young JR, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267(2):444–453CrossRefPubMed Young JR, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267(2):444–453CrossRefPubMed
24.
go back to reference Rosenkrantz AB, Hindman N, Fitzgerald EF, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. Am J Roentgenol 195(6):W421–W427CrossRef Rosenkrantz AB, Hindman N, Fitzgerald EF, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. Am J Roentgenol 195(6):W421–W427CrossRef
25.
go back to reference Kang SK, Huang WC, Pandharipande PV, et al. (2014) Solid renal masses: what the numbers tell us. Am J Roentgenol 202(6):1196–1206CrossRef Kang SK, Huang WC, Pandharipande PV, et al. (2014) Solid renal masses: what the numbers tell us. Am J Roentgenol 202(6):1196–1206CrossRef
26.
go back to reference Gerst S, Hann LE, Li D, et al. (2011) Evaluation of renal masses with contrast-enhanced ultrasound: initial experience. Am J Roentgenol 197(4):897–906CrossRef Gerst S, Hann LE, Li D, et al. (2011) Evaluation of renal masses with contrast-enhanced ultrasound: initial experience. Am J Roentgenol 197(4):897–906CrossRef
27.
go back to reference Wu Y, Du L, Li F, et al. (2013) Renal oncocytoma: contrast-enhanced sonographic features. J Ultrasound Med 32(3):441–448CrossRefPubMed Wu Y, Du L, Li F, et al. (2013) Renal oncocytoma: contrast-enhanced sonographic features. J Ultrasound Med 32(3):441–448CrossRefPubMed
28.
go back to reference Tamai H, Takiguchi Y, Oka M, et al. (2005) Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med 24(12):1635–1640CrossRefPubMed Tamai H, Takiguchi Y, Oka M, et al. (2005) Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med 24(12):1635–1640CrossRefPubMed
29.
go back to reference Bhatt S, MacLennan G, Dogra V (2007) Renal pseudotumors. Am J Roentgenol 188(5):1380–1387CrossRef Bhatt S, MacLennan G, Dogra V (2007) Renal pseudotumors. Am J Roentgenol 188(5):1380–1387CrossRef
30.
go back to reference Ascenti G, Zimbaro G, Mazziotti S, et al. (2001) Contrast-enhanced power Doppler US in the diagnosis of renal pseudotumors. Eur Radiol 11(12):2496–2499CrossRefPubMed Ascenti G, Zimbaro G, Mazziotti S, et al. (2001) Contrast-enhanced power Doppler US in the diagnosis of renal pseudotumors. Eur Radiol 11(12):2496–2499CrossRefPubMed
31.
go back to reference Mazziotti S, Zimbaro F, Pandolfo A, et al. (2010) Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors. Abdom Imaging 35(2):241–245CrossRefPubMed Mazziotti S, Zimbaro F, Pandolfo A, et al. (2010) Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors. Abdom Imaging 35(2):241–245CrossRefPubMed
32.
go back to reference Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113(Suppl 1):5–13CrossRef Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113(Suppl 1):5–13CrossRef
33.
go back to reference Demertzis J, Menias CO (2007) State of the art: imaging of renal infections. Emerg Radiol 14:13–22CrossRefPubMed Demertzis J, Menias CO (2007) State of the art: imaging of renal infections. Emerg Radiol 14:13–22CrossRefPubMed
34.
go back to reference Mitterberger M, Pinggera GM, Colleselli D, et al. (2007) Acute pyelonephritis: comparison of diagnosis with computed tomography and contrast enhanced ultrasonography. BJU Int 101(3):341–344CrossRefPubMed Mitterberger M, Pinggera GM, Colleselli D, et al. (2007) Acute pyelonephritis: comparison of diagnosis with computed tomography and contrast enhanced ultrasonography. BJU Int 101(3):341–344CrossRefPubMed
35.
go back to reference Fontanilla T, Minaya J, Cortés C, et al. (2012) Acute complicated pyelonephritis: contrast-enhanced ultrasound. Abdom Imaging 37(4):639–646CrossRefPubMed Fontanilla T, Minaya J, Cortés C, et al. (2012) Acute complicated pyelonephritis: contrast-enhanced ultrasound. Abdom Imaging 37(4):639–646CrossRefPubMed
36.
go back to reference Morichetti D, Mazzucchelli R, Lopez-Beltran A, et al. (2009) Secondary neoplasms of the urinary system and male genital organs. BJU Int 104(6):770–776CrossRefPubMed Morichetti D, Mazzucchelli R, Lopez-Beltran A, et al. (2009) Secondary neoplasms of the urinary system and male genital organs. BJU Int 104(6):770–776CrossRefPubMed
37.
go back to reference Honda H, Coffman CE, Berbaum KS, Barloon TJ, Masuda K (1992) CT analysis of metastatic neoplasms of the kidney. Comparison with primary renal cell carcinoma. Acta Radiol 33(1):39–44CrossRefPubMed Honda H, Coffman CE, Berbaum KS, Barloon TJ, Masuda K (1992) CT analysis of metastatic neoplasms of the kidney. Comparison with primary renal cell carcinoma. Acta Radiol 33(1):39–44CrossRefPubMed
39.
go back to reference Penn I, Brunson ME (1988) Cancers after cyclosporine therapy. Transplant Proc 20(suppl 3):885–892PubMed Penn I, Brunson ME (1988) Cancers after cyclosporine therapy. Transplant Proc 20(suppl 3):885–892PubMed
Metadata
Title
Applications of contrast-enhanced ultrasound in the kidney
Authors
Brittany Kazmierski
Corinne Deurdulian
Hisham Tchelepi
Edward G. Grant
Publication date
01-04-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 4/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1307-0

Other articles of this Issue 4/2018

Abdominal Radiology 4/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.